These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11814471)

  • 1. Development of the diagnostic immunoassay to detect anti-PreS1(21-47aa) antibody--a marker suggesting the health improvement of hepatitis B patients.
    Wei J; Liu XJ; Wang YQ; Lu ZM; Li GD; Wang Y; Zhang ZC
    Clin Chim Acta; 2002 Mar; 317(1-2):159-69. PubMed ID: 11814471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of anti-preS1 antibodies for recovery of hepatitis B patients by immunoassay.
    Wei J; Wang YQ; Lu ZM; Li GD; Wang Y; Zhang ZC
    World J Gastroenterol; 2002 Apr; 8(2):276-81. PubMed ID: 11925607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A flexible peptide linker enhances the immunoreactivity of two copies HBsAg preS1 (21-47) fusion protein.
    Hu W; Li F; Yang X; Li Z; Xia H; Li G; Wang Y; Zhang Z
    J Biotechnol; 2004 Jan; 107(1):83-90. PubMed ID: 14687974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the PreS1 peptide of hepatitis B virus and preparation of its polyclonal antibody.
    Chen W; Zhang J; Zhang J; Wang D; Li Y; Huang A
    Hybridoma (Larchmt); 2011 Dec; 30(6):525-30. PubMed ID: 22149277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and immunoactivity of chimeric particulate antigens of receptor binding site-core antigen of hepatitis B virus.
    Yang HJ; Chen M; Cheng T; He SZ; Li SW; Guan BQ; Zhu ZH; Gu Y; Zhang J; Xia NS
    World J Gastroenterol; 2005 Jan; 11(4):492-7. PubMed ID: 15641132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A monoclonal antibody specific to the non-epitope region of hepatitis B virus preS1 contributes to more effective HBV detection.
    Zhang Z; Li X; Yi W; Li S; Hu C; Chen A
    Clin Biochem; 2013 Aug; 46(12):1105-1110. PubMed ID: 23608352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and characterization of the multiplied, recombinant preS1 antigen of hepatitis B virus.
    Sidorkiewicz M; Płucienniczak G; Płucienniczak A
    Arch Virol; 1995; 140(11):1935-44. PubMed ID: 7503692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and structural analysis of the hepatitis B virus preS1 expressed from Escherichia coli.
    Maeng CY; Oh MS; Park IH; Hong HJ
    Biochem Biophys Res Commun; 2001 Apr; 282(3):787-92. PubMed ID: 11401532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse monoclonal antibodies to hepatitis B virus preS1 produced after immunization with recombinant preS1 peptide.
    Ryu CJ; Kim YK; Hur H; Kim HS; Oh JM; Kang YJ; Hong HJ
    Hybridoma; 2000 Apr; 19(2):185-9. PubMed ID: 10868800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine mapping of virus-neutralizing epitopes on hepatitis B virus PreS1.
    Maeng CY; Ryu CJ; Gripon P; Guguen-Guillouzo C; Hong HJ
    Virology; 2000 Apr; 270(1):9-16. PubMed ID: 10772975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and characterization of the preS1 peptide of hepatitis B surface antigen in Escherichia coli.
    Lin Y; Liu YX; Cislo T; Mason BL; Yu MY
    J Med Virol; 1991 Mar; 33(3):181-7. PubMed ID: 1880495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody response to preS1 in hepatitis-B-virus-induced liver disease and after immunization.
    Coursaget P; Buisson Y; Bourdil C; Yvonnet B; Molinié C; Diop MT; Chiron JP; Bao O; Diop-Mar I
    Res Virol; 1990; 141(5):563-70. PubMed ID: 2148981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus.
    Bremer CM; Sominskaya I; Skrastina D; Pumpens P; El Wahed AA; Beutling U; Frank R; Fritz HJ; Hunsmann G; Gerlich WH; Glebe D
    J Hepatol; 2011 Jul; 55(1):29-37. PubMed ID: 21145866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression, Purification and Preliminary Clinical Use of Recombinant HBsAg GST-PreS1(21--47 aa) Fusion Proteins.
    Wei J; Liu XJ; Li GD; Wang Y; Zhang ZC; Wang YQ; Lu ZM
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2001; 33(4):379-385. PubMed ID: 12040409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the minimal length of preS1 epitope recognized by a monoclonal antibody which inhibits attachment of hepatitis B virus to hepatocytes.
    Sominskaya I; Pushko P; Dreilina D; Kozlovskaya T; Pumpen P
    Med Microbiol Immunol; 1992; 181(4):215-26. PubMed ID: 1279369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavior of a short preS1 epitope on the surface of hepatitis B core particles.
    Borisova G; Borschukova O; Skrastina D; Dislers A; Ose V; Pumpens P; Grens E
    Biol Chem; 1999 Mar; 380(3):315-24. PubMed ID: 10223334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo neutralization of hepatitis B virus infection by an anti-preS1 humanized antibody in chimpanzees.
    Hong HJ; Ryu CJ; Hur H; Kim S; Oh HK; Oh MS; Park SY
    Virology; 2004 Jan; 318(1):134-41. PubMed ID: 14972542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical and epidemiological significance of serum PreS1/anti-PreS1 in HBV infection.
    Mi Z; Feng F; Zhang X; Lian Z; Wang H; Tong Y
    Chin Med J (Engl); 1999 Apr; 112(4):321-4. PubMed ID: 11593530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the immunogenic domains in HBsAg preS1 region using overlapping preS1 fragment fusion proteins.
    Hu WG; Wei J; Xia HC; Yang XX; Li F; Li GD; Wang Y; Zhang ZC
    World J Gastroenterol; 2005 Apr; 11(14):2088-94. PubMed ID: 15810073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High level expression of hepatitis B virus preS1 peptide in Escherichia coli.
    Rhyum SB; Jin BR; Park HR; Hong HJ
    J Biotechnol; 1994 Aug; 36(3):221-30. PubMed ID: 7765264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.